Navigation Links
Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine
Date:5/13/2009

NIH Grant will also Fund Research of Advanced Technologies for Early Disease Detection

DALLAS, May 13 /PRNewswire-USNewswire/ -- Scientists at Baylor Institute for Immunology Research (BIIR) in Dallas, part of Baylor Research Institute (BRI) and the Baylor Health Care System, announced today that they received a renewal of a multi-million dollar grant from the National Institutes of Health (NIH) to design new vaccines to prevent influenza - including swine flu (H1N1). The grant will also help BRI develop advanced technologies that could be used for early detection of many other diseases, such as cancer, autoimmune diseases and infectious diseases.

This research has been supported for the past six years by the National Institute of Allergy and Infectious Diseases (NIAID), a department of the NIH. The original grant, received in 2003, totaled $16.5 million and has just been renewed by the NIAID for another five years at close to $14 million.

"We have made great progress over the past six years because of this grant. We now know that certain types of immune system cells are better for inducing immunity to the flu. We also know how to target them with molecules that we have developed at BRI," says Jacques Banchereau, Ph.D., director, Baylor Institute for Immunology Research. "With the new funding from the NIAID, we plan to further characterize our targeting molecules and continue to measure the immune response to the flu. This will prepare us for a clinical trial to test our new vaccine."

Additionally, BRI scientists have applied for a supplement to the grant that would allow them to specifically make a vaccine against swine flu. It would also fund studies researching how swine flu affects the immune systems of patients.

"There is serious concern throughout the world health communities about the dangers of emerging infectious diseases, like this new flu strain," says Dr. Banchereau. "Our flu research has focused on finding out how the immune system responds to the flu and on developing a new type of vaccine that will activate a strong protection against the flu."

To develop this vaccine, the researchers will target dendritic cells, key immune system cells that instruct the rest of the immune system to develop immunity against invading microbes.

Another project at BRI has expanded into a new Center for Personalized Medicine led by Damien Chaussabel, Ph.D., a scientist at BIIR. This new center is using microarray technology to measure the expression of over 45,000 genes from a single tube of a patient's blood. What they have found is that the immune system responds in unique ways to different kinds of diseases. This allows the researchers to identify a "biosignature," which can be used to diagnose diseases. This technology might one day be used in doctors' offices and hospitals to diagnose swine flu and other diseases.

"The work being carried out at BRI has the potential to transform the way that we treat patients and diagnose diseases, including those infected with swine flu," says Michael Ramsay, M.D., president, Baylor Research Institute.

Dallas-based Baylor Research Institute, an affiliate of Baylor Health Care System, promotes research that brings innovative treatments from the laboratory to the patient bedside. The Institute focuses on basic and translational science, clinical trials, health care effectiveness and quality of care research. Currently, investigators at Baylor are conducting 800 active research protocols spanning more than 20 medical specialties. Opened in 1996, Baylor Institute for Immunology Research, a component of BRI, focuses on developing new therapies to treat conditions that involve the immune system such as cancer, autoimmune diseases, infectious diseases and organ transplantation.

For more information about the Baylor Research Institute, visit www.BaylorHealth.com. For more information about BIIR, visit www.BIIR.org.


'/>"/>
SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Baylor Dallas Nationally Recognized for Nursing Excellence
2. Bill Lively Joins Baylor Health Care System Foundation as Senior Strategic Development Consultant
3. Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer
4. Evelyn Y. Davis, Shareholder Advocate, and the Evelyn Y. Davis Foundation Donate $100,000 to Riggs Emergency Department at Baylor University Medical Center at Dallas
5. National Quality Forum Names Baylor Health Care System Winner of 2008 NQF National Quality Healthcare Award
6. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
7. Baylor Health Care System Receives National Information Technology Recognition
8. Genomic Health to Present at JMP Securities Research Conference
9. Rigel to Present at JMP Securities Research Conference
10. KLRI Releases 3rd Annual Report On Years Top Longevity Research Findings
11. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Urinary Incontinence Drugs Price ... in the global Urinary Incontinence market. The research answers the ... drugs marketed for Urinary Incontinence and their clinical attributes? How are ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology: